| # | Title | Journal | Year | Citations |
|---|
| 1 | The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD | Modern Rheumatology | 2021 | 219 |
| 2 | Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis | Modern Rheumatology | 2019 | 104 |
| 3 | 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases | Modern Rheumatology | 2021 | 49 |
| 4 | 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease | Respiratory Investigation | 2021 | 45 |
| 5 | Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study | Modern Rheumatology | 2019 | 34 |
| 6 | Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study | Arthritis Research and Therapy | 2018 | 33 |
| 7 | Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan | Modern Rheumatology | 2017 | 28 |
| 8 | Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies | Rheumatology | 2017 | 27 |
| 9 | Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study | Scandinavian Journal of Rheumatology | 2019 | 20 |
| 10 | Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation | Journal of Immunology | 2019 | 15 |
| 11 | Clinicopathological characteristics of lymphoproliferative disorders in 232 patients with rheumatoid arthritis in Japan: A retrospective, multicenter, descriptive study | Modern Rheumatology | 2022 | 15 |
| 12 | Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospective, multicenter, case–control study | Modern Rheumatology | 2022 | 13 |
| 13 | Persistent anemia and hypoalbuminemia in rheumatoid arthritis patients with low serum triiodothyronine level | Modern Rheumatology | 2020 | 10 |
| 14 | Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance | Modern Rheumatology | 2023 | 9 |
| 15 | Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study | Advances in Rheumatology | 2021 | 8 |
| 16 | Anti-nuclear antibody development is associated with poor treatment response to biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis | Seminars in Arthritis and Rheumatism | 2019 | 7 |
| 17 | Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study | Modern Rheumatology | 2022 | 7 |
| 18 | Intake frequency of vegetables or seafoods negatively correlates with disease activity of rheumatoid arthritis | PLoS ONE | 2020 | 7 |
| 19 | Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study | Modern Rheumatology | 2021 | 6 |
| 20 | Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisis | Rheumatology | 2022 | 6 |
| 21 | Overall survival and post-spontaneous regression relapse-free survival of patients with lymphoproliferative disorders associated with rheumatoid arthritis: a multi-center retrospective cohort study | Modern Rheumatology | 2022 | 4 |
| 22 | AB0249 SAFETY OF BARICITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS (RA): THE 2020 INTERIM REPORT FROM ALL-CASE POST MARKETING SURVEILLANCE IN CLINICAL PRACTICE | Annals of the Rheumatic Diseases | 2021 | 3 |
| 23 | Severe systemic inflammation mimicking TAFRO syndrome following COVID-19 | International Journal of Hematology | 2023 | 3 |
| 24 | Hypertrophic pachymeningitis and subdural haematoma in an otitis media with ANCA-associated vasculitis patient successfully treated with intravenous cyclophosphamide | Modern Rheumatology Case Reports | 2019 | 1 |
| 25 | AB0653 The association of autoantibodies with morbidity and mortality of scleroderma renal crisis in Japan | Annals of the Rheumatic Diseases | 2022 | 1 |
| 26 | Concordance between practice and published evidence in the management of ANCA-associated vasculitis in Japan: A cross-sectional web-questionnaire survey | Modern Rheumatology | 2023 | 1 |
| 27 | 15. Clinical Manifestations and Treatment in Patients with Systemic Lupus Erythematosus | The Journal of the Japanese Society of Internal Medicine | 2019 | 0 |
| 28 | 8. Clinical and Pathological Significances of Autoantibodies in Patients with Systemic Rheumatic Diseases | The Journal of the Japanese Society of Internal Medicine | 2019 | 0 |
| 29 | 15. Clinical Manifestations and Treatment in Patients with Systemic Lupus Erythematosus | The Journal of the Japanese Society of Internal Medicine | 2019 | 0 |
| 30 | Forearm porphyrin levels evaluated by digital imaging system are increased in patients with systemic sclerosis compared with patients in pre-clinical stage | Intractable and Rare Diseases Research | 2022 | 0 |
| 31 | Evaluation of asymptomatic cerebral ischemia by arterial spin-labeling magnetic resonance imaging of the brain in Takayasu arteritis | Rheumatology | 0 | 0 |
| 32 | Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database | Modern Rheumatology | 2024 | 0 |
